BioWorld

July 6, 2000

View Archived Issues

Cell Pathways Gains Oncology Presence Through Aventis Deal

Read More

FDA Grants Gilead's AmBisome Approval For New Indication

Read More

Anthrax Bacterium's Toxin Gets Make-Over As Key Item In Killer T Cell-Stimulating HIV Vaccine

Read More

Other News To Note

Read More

European Patent Disclosures

Read More